CMBI Private Equity Series SPC - Net Worth and Insider Trading
CMBI Private Equity Series SPC Net Worth
The estimated net worth of CMBI Private Equity Series SPC is at least $429 Million dollars as of 2025-07-23. CMBI Private Equity Series SPC is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd and owns about 20,779,544 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) stock worth over $429 Million. Details can be seen in CMBI Private Equity Series SPC's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that CMBI Private Equity Series SPC has not made any transactions after 2025-06-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of CMBI Private Equity Series SPC
CMBI Private Equity Series SPC Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, CMBI Private Equity Series SPC owns 1 companies in total, including Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) .
Click here to see the complete history of CMBI Private Equity Series SPC’s form 4 insider trades.
Insider Ownership Summary of CMBI Private Equity Series SPC
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02315 | Biocytogen Pharmaceuticals (Beijing) Co Ltd | 2025-06-30 | 2201 Interest of corporation controlled by you |
CMBI Private Equity Series SPC Latest Holdings Summary
CMBI Private Equity Series SPC currently owns a total of 1 stock. CMBI Private Equity Series SPC owns 20,779,544 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) as of June 25, 2025, with a value of $429 Million.
Latest Holdings of CMBI Private Equity Series SPC
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02315 | Biocytogen Pharmaceuticals (Beijing) Co Ltd | 2025-06-25 | 20,779,544 | 20.65 | 429,097,584 |
Holding Weightings of CMBI Private Equity Series SPC
CMBI Private Equity Series SPC Form 4 Trading Tracker
According to the SEC Form 4 filings, CMBI Private Equity Series SPC has made a total of 3 transactions in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Biocytogen Pharmaceuticals (Beijing) Co Ltd is the sale of 538,500 shares on June 25, 2025, which brought CMBI Private Equity Series SPC around $0.
Insider Trading History of CMBI Private Equity Series SPC
- 1
CMBI Private Equity Series SPC Trading Performance
CMBI Private Equity Series SPC Ownership Network
Ownership Network List of CMBI Private Equity Series SPC
Ownership Network Relation of CMBI Private Equity Series SPC
CMBI Private Equity Series SPC Owned Company Details
What does Biocytogen Pharmaceuticals (Beijing) Co Ltd do?
Who are the key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd?
CMBI Private Equity Series SPC is the 2201 Interest of corporation controlled by you of Biocytogen Pharmaceuticals (Beijing) Co Ltd. Other key executives at Biocytogen Pharmaceuticals (Beijing) Co Ltd include 2102 Investment manager LAKE BLEU CAPITAL (Hong Kong) LIMITED , 2101 Beneficial owner Astral Eminent Limited , and 2201 Interest of corporation controlled by you zhao shang yin xing gu fen you xian gong si .
Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) Insider Trades Summary
Over the past 18 months, CMBI Private Equity Series SPC made 2 insider transaction in Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) with a net sale of 5,308,936. Other recent insider transactions involving Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) include a net sale of 5,308,936 shares made by zhao yin guo ji jin rong kong gu you xian gong si , a net sale of 5,308,936 shares made by Astral Eminent Limited , and a net sale of 5,308,936 shares made by CMB International Private Investment Limited .
In summary, during the past 3 months, insiders sold 37,725,052 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) in total and bought 81,500 shares, with a net sale of 37,643,552 shares. During the past 18 months, 37,725,052 shares of Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315) were sold and 1,081,500 shares were bought by its insiders, resulting in a net sale of 36,643,552 shares.
Biocytogen Pharmaceuticals (Beijing) Co Ltd (HKSE:02315)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biocytogen Pharmaceuticals (Beijing) Co Ltd Insider Transactions
CMBI Private Equity Series SPC Mailing Address
Above is the net worth, insider trading, and ownership report for CMBI Private Equity Series SPC. Currently GuruFocus does not have mailing address information for CMBI Private Equity Series SPC.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
